Adjuvant chemoradiation with weekly cisplatin did not significantly improve survival outcomes — but did increase toxicities — compared with adjuvant radiotherapy alone in women with early-stage cervical carcinoma who have intermediate risk factors following radical hysterectomy, a phase 3 trial found. The current standard for women with early-stage disease and intermediate-risk factors is radiotherapy alone...
112 N Bayshore Blvd #3 San Mateo, Ca 94401
650-544-0793
jamesfgraham111@gmail.com
Copyright © 2024 botnik. All Rights Reserved
